Actively Recruiting
Evaluating a Chatbot Program to Reduce Internet Gaming and Social Media Addiction, Sedentary Habits, and Mental Stress in Adolescents Aged 10 to 19
Led by Chinese University of Hong Kong · Updated on 2025-02-12
330
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of a low-intensity chatbot intervention based on the stages of change and motivational interviewing to reduce digital addictions in adolescents aged 10 to 19 years. The study focuses on Internet gaming disorder IGD and social media addiction SMA, comparing the chatbot-assisted program to a psycho-educational control group. This randomized controlled trial aims to see if the chatbot group shows greater reductions in IGD and SMA rates after treatment and at a 3-month follow-up. Participants are randomly assigned to either the chatbot intervention or a psycho-educational control group. The chatbot intervention consists of five weekly modules tailored to the participants stage of change, delivered via WhatsApp and taking about 10-15 minutes per module, totaling one hour. The control group receives educational materials about digital use and addictions but without the stages of change or motivational interviewing elements. Throughout the study, participants complete questionnaires assessing primary outcomes like IGD and SMA, as well as secondary outcomes including sedentary lifestyle, mental distress, quality of life, and eHealth literacy. Evaluations occur at screening, baseline, post-program, and at 3-month follow-up. The study monitors motivation and self-efficacy as mechanisms behind changes. Total participation spans from enrollment through the 3-month follow-up period.
CONDITIONS
Brief Title
Chatbot Intervention to Reduce Common Digital Addictions, Sedentary Behaviors and Mental Distress Among Adolescents
Research Team
X
Xue Yang, Doctoral
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here